OZON Pharmaceuticals has signed a ‘musataha agreement’ to establish a 150,700 sq. ft. manufacturing facility at Dubai Industrial City. With a two-phase AED293 million ($80 million) investment, the new facility at Dubai Industrial City, part of TECOM Group, is set to operate at full capacity by next year.
Saud Abu Alshawareb, Executive Vice President of Industrial Leasing at Dubai’s TECOM Group, signed the agreement with Dr. Mustafa Khalaf, General Manager at OZON Pharmaceuticals, on the sidelines of INNOPROM 2024 in Ekaterinburg, Russia.
AED110 million phase 1 investment
Phase 1 of the OZON Pharmaceuticals Dubai facility will receive an investment of AED110 million. In addition, it will have a production capacity of more than 300 million tablets annually. Upon completion, the facility will serve key markets in the GCC and other regional countries.
“Localised medical manufacturing strengthens supply chains, response times, and self-sufficiency, all of which are essential levers to embed resilience in the healthcare sector,” Abu Alshawareb said.
He added that achieving such socioeconomic security through the manufacturing sector is among the visions of Operation 300bn. Moreover, it aligns with the targets of Make it in the Emirates and Dubai Economic Agenda ‘D33’ strategies.
Read: PureHealth revenues surge 53 percent to $3.4 billion in H1 2024
Cutting-edge medicine tracking systems
In the initial phase, 100 employees across specializations like quality assurance, pharmaceutical control and manufacturing will work at the facility. Notably, OZON Pharmaceuticals’ Dubai facility will feature cutting-edge medicine tracking systems. This provides traceability and security through all stages of the product development lifecycle.
“Our vision through the launch of this facility is to have a positive impact on the manufacturing and healthcare sectors in the UAE, the wider Middle East, and the CIS regions by ensuring a consistent supply of high-quality medicines,” stated Khalaf. OZON Pharmaceuticals’ general manager added that the Dubai facility aims to foster technological innovation and elevate the standards of healthcare delivery across the regions.
OZON Pharmaceuticals is the latest medical leader to join Dubai Industrial City. The city is now home to over 1,000 local, regional and international customers. This includes Standard Carpets, Himalaya Wellness, IFFCO Group and Unilever. Moreover, it includes over 300 operational factories.
For more stories on health, click here.
